How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Collection Devices Market
- By Product Type: Vacuum Blood Collection Tubes, Syringes and Needles, Capillary Blood Collection Devices, Blood Collection Sets, Lancets
- By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Ambulatory Surgical Centers, Home Healthcare Settings
- By Material Type: Plastic Blood Collection Tubes, Glass Blood Collection Tubes, Stainless Steel Needles, Latex-Free Components
- By Application: Clinical Diagnostics, Blood Donation, Therapeutic Drug Monitoring, Research and Development
- By Technology: Closed Blood Collection Systems, Open Blood Collection Systems, Safety-Engineered Blood Collection Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Vacuum Blood Collection Tubes leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Blood Collection Devices Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
End User 5
Material Type 4
Application 4
Technology 3
Companies profiled
Becton Dickinson and Company (BD)
Terumo Corporation
Greiner Bio-One International GmbH
Sarstedt AG & Co.
SteriPath
Nipro Corporation
Fresenius Kabi AG
Pall Corporation (a part of Danaher)
Smiths Medical (part of ICU Medical)
B. Braun Melsungen AG
Haemonetics Corporation
Sekisui Diagnostics
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sarstedt AG & Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →SteriPath
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Fresenius Kabi AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Pall Corporation (a part of Danaher)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Smiths Medical (part of ICU Medical)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Haemonetics Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sekisui Diagnostics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Vacuette (Greiner Bio-One)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Ningbo Medical Needle Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$1,237M by 2033 · 7.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Vacuum Blood Collection Tubes38.6
- Syringes and Needles13.4
- Capillary Blood Collection Devices10.3
- Blood Collection Sets16.0
- Lancets21.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$235.8M → $395.0M · 6.7%
Europe$164.3M → $269.0M · 6.4%
Asia Pacific$150.0M → $268.8M · 7.6%
Latin America$92.9M → $158.3M · 6.9%
Middle East and Africa$71.4M → $128.2M · 7.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.052026
7.072027
7.092028
7.102029
7.102030
7.122031
7.132032
7.152033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton Dickinson and Company (BD)10.3
- Terumo Corporation23.6
- Greiner Bio-One International GmbH7.4
- Sarstedt AG & Co.11.3
- SteriPath10.6
- Nipro Corporation8.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type21.3%
End User36.9%
Material Type15.6%
Application13.9%
Technology12.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.4
- Europe22.1
- Asia Pacific22.0
- Latin America13.0
- Middle East and Africa10.5
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | 94 | 95 | 90 | 76 | 87 | 84 | 88 |
| Terumo Corporation | 90 | 83 | 88 | 86 | 77 | 83 | 85 |
| Greiner Bio-One International GmbH | 74 | 79 | 79 | 77 | 65 | 84 | 76 |
| Sarstedt AG & Co. | 70 | 60 | 60 | 57 | 58 | 78 | 64 |
| SteriPath | 51 | 52 | 71 | 59 | 53 | 64 | 58 |
| Nipro Corporation | 48 | 50 | 71 | 57 | 64 | 65 | 59 |
| Fresenius Kabi AG | 57 | 51 | 65 | 54 | 46 | 44 | 53 |
| Pall Corporation (a part of Danaher) | 47 | 53 | 60 | 53 | 38 | 42 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton Dickinson and Company (BD)
- Terumo Corporation
- Greiner Bio-One International GmbH
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Terumo Corporation | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Greiner Bio-One International GmbH | ◐ | ✓ | ◐ | ◐ | − | ✓ |
| Sarstedt AG & Co. | ◐ | − | − | − | ◐ | ◐ |
| SteriPath | ◐ | − | ✓ | ◐ | − | ✓ |
| Nipro Corporation | − | − | ◐ | ◐ | ◐ | − |
| Fresenius Kabi AG | ◐ | − | ◐ | ◐ | − | − |
| Pall Corporation (a part of Danaher) | − | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton Dickinson and Company (BD)88
2Terumo Corporation85
3Greiner Bio-One International GmbH76
4Sarstedt AG & Co.64
5Nipro Corporation59
6SteriPath58
7Fresenius Kabi AG53
8Pall Corporation (a part of Danaher)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Becton Dickinson and Company (BD)Terumo Corporation
Challenger1
Strong scale, closing on the leaders.
Greiner Bio-One International GmbH
Contender3
Focused players with pockets of strength.
Sarstedt AG & Co.SteriPathNipro Corporation
Niche2
Specialists in a single segment or region.
Fresenius Kabi AGPall Corporation (a part of Danaher)
Go-to-market strategy
Land Product Type in North America, then scale across Blood Collection Devices Market — a $541M beachhead inside a $7.39B market.
Beachhead (SOM)$541Mobtainable near-term
Serviceable (SAM)$3.10Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Vacuum Blood Collection Tubes
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Syringes and Needles
Strong fit — clear ROI and a fast path to value.
End user70 fit
Capillary Blood Collection Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Material Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel27%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Collection Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified20%
Evaluation13%
Closed-won6%
$16.2KCAC
$68KLTV
4.2:1LTV : CAC
< 3 moCAC payback
Investment thesis
Blood Collection Devices Market is a durable-growth opportunity — $3.56B by 2033, compounding at 6.2%.
TAM · 2025$2.20Btoday
TAM · 2033$3.56Bforecast
CAGR6.2%2027–2033
Cumulative$25.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.56BTotal addressable market
SAM$1.45BServiceable available market
SOM$309MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.56BLarge & growingTAM by 2033 at 6.2% CAGR
$1.45BServiceable nowreachable with today’s model
$309MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.78BBear4.0% CAGR
$3.56BBase6.2% CAGR
$4.56BBull8.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Collection Devices Market — a $1.34B market by 2033. Plan: grow share from 8.2% to 16.2%.
Market size · 2033$1.34Btotal addressable
Market CAGR8.5%2027–2033
Target share16.2%from 8.2% today
Revenue ambition$218Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 16.2% | On track |
| Revenue | $106M | $218M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.1% | 38.9% | At risk |
| Customer retention | 86.6% | 93.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $22M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Sales deck · value proposition
Win the Blood Collection Devices Market conversation — a $1.64B market you can size, segment and defend in minutes.
Market size · 2033$1.64Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers1,074+accounts in scope
Typical ROI5.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.9×return on cost, year one
< 3 mopayback period
$76K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Becton Dickinson and Company (BD)Terumo CorporationGreiner Bio-One International GmbHSarstedt AG & Co.SteriPathNipro CorporationFresenius Kabi AGPall Corporation (a part of Danaher)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Collection Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Collection Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Collection Equipment Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Collection Manager Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBlood Collection Products for Veterinary Use Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBlood Collection System Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportBlood Collection Tube for Noninvasive Prenatal Testing (NIPT) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Collection Tubes (BCT) Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBlood Collection Tubes and Vials Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Component Extractor Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBlood Conservation Device Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBlood Conversation System Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportBlood Culture Devices Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Culture Test Device Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.